GENOMIC HEALTH INC·4

Feb 21, 7:25 PM ET

Radford Jason W. 4

4 · GENOMIC HEALTH INC · Filed Feb 21, 2019

Insider Transaction Report

Form 4
Period: 2019-02-19
Radford Jason W.
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2019-02-19$83.73/sh619$51,83134,888 total
  • Sale

    Common Stock

    2019-02-19$83.03/sh2,889$239,87835,507 total
Footnotes (5)
  • [F1]These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 15, 2018.
  • [F2]Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
  • [F3]Represents weighted average sale price. Actual sale prices ranged from $82.59 to $83.58.
  • [F4]Includes an aggregate of 31,517 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
  • [F5]Represents weighted average sale price. Actual sale prices ranged from $83.63 to $83.97.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION